amorphous solid dispersion

Imagine scattering grains of sugar so thoroughly through a block of jelly that no two grains ever touch and none can clump back into a crystal. An amorphous solid dispersion does this with a drug: each drug molecule is spread out and locked inside a solid polymer matrix, kept apart so it cannot crystallize. The result is a stable way to deliver the high-solubility amorphous form of a poorly soluble drug.

The amorphous state dissolves faster and reaches higher concentrations than the crystal, but on its own it tends to crystallize and lose that advantage. The polymer solves this by physically immobilizing the drug molecules and chemically interacting with them, raising the temperature at which the mixture would soften and slowing crystallization to a crawl. When the dispersion dissolves, it can release the drug into a supersaturated solution, well above the drug's normal solubility, giving a window for absorption.

These systems are usually made by spray drying a drug-polymer solution or by hot-melt extrusion, which blends drug and polymer under heat and shear. The trade-offs are real: the polymer dilutes the drug so the dose can become bulky, the manufacturing is more complex, and physical stability must be proven over the product's shelf life, since any creeping crystallization erases the solubility benefit. Even so, amorphous solid dispersions have rescued many otherwise undeliverable molecules.